Introduction
Terminal differentiation, negative growth control, and MyD/Gadd genes Animal cells respond to dierentiation signals which turn on or o the appropriate genes, resulting in the conversion of proliferating, undierentiated cells into nonproliferating, highly specialized dierentiated cells. Two interrelated cellular processes are invoked simultaneously upon induction of dierentiation, the regulated progression of cells through successive stages of cell dierentiation and growth inhibition which ultimately leads to growth arrest. In tissues with rapid cell turnover terminally dierentiated cells undergo programmed cell death. Thus, terminal dierentiation can be viewed as one form of negative growth control. A profound example of this process, which continues throughout life, is the complex process of blood cell formation, whereby a hierarchy of hematopoietic progenitor cells in the bone marrow proliferate and terminally dierentiate along multiple, distinct cell lineages, including proliferation and terminal dierentiation of cells along the myeloid lineage.
To better understand the molecular pathways that control terminal dierentiation, Myeloid Dierentiation primary response (MyD) genes, induced, in the absence of de novo protein synthesis upon the onset of M1 leukemic myeloblasts for terminal dierentiation by IL-6, have been isolated in our laboratory ( Figure  1a ) (Abdollahi et al., 1991a,b; Lord et al., 1990a,b,c,d; Nguyen et al., 1993) . MyD genes also were found to be induced during terminal dierentiation which is coupled to cell proliferation in normal bone-marrow derived myeloblasts (Figure 1b) (Abdollahi et al., 1991a,b; Lord et al., 1990a,b,c,d; Nguyen et al., 1993) . Since terminal dierentiation is associated with growth arrest and apoptosis, it is not surprising, that many of the genes identi®ed as MyD genes, including both known genes (IRF-1, Jun. Egr-1) (Abdollahi et al., 1991a; Lord et al., 1990a; Nguyen et al., 1993) and novel ones (MyD88, MyD116/Gadd34, MyD118 (Gadd45b)) (Abdollahi et al., 1991b; Lord et al., 1990c,d) , turned out to play a role in negative growth control, including growth suppression and apoptosis. In recent years it has become evident that MyD genes also play a prominent role in host immunity and in¯ammation, consistent with their role as myeloid dierentiation primary response genes. This review will examine the role MyD genes play in terminal dierentiation and function of hematopoietic cells, including in immunity and in¯ammation.
Interferon regulatory factor 1 (IRF-1/MyD32) in hematopoiesis, immunity and negative growth control Interferon regulatory factor-1 (IRF-1), a transcriptional activator of the interferon-b (IFN-b) gene (Fujita et al., 1989; Harada et al., 1990; Miyamoto et al., 1988) , has been isolated in this laboratory as MyD32, a MyD gene that was observed to be highly expressed in normal myeloblast enriched bone-marrow cells (Abdollahi et al., 1991a) . IRF-1/MyD32 was observed to be rapidly induced in the absence of de novo protein synthesis in M1 myeloblastic leukemia cells induced for terminal dierentiation by IL-6 or leukemia inhibitory factor (LIF). IRF-1 induction in M1 cells appears to be essential for expression of interferon-b (IFN-b) that is induced at later times (Abdollahi et al., 1991a;  Figure 1 ). Growth suppression of M1 cells, which is associated with terminal dierentiation, was found to be partially abrogated by IRF-1 antisense oligomers or IFN-b antiserum (Abdollahi et al., 1991a) . Taken together, these ®ndings have revealed a regulatory cascade, where induction of terminal myeloid dierentiation by IL-6 or LIF triggers immediate early activation of IRF-1 inducing IFN-b expression, which in turn plays an autocrine role in growth inhibition associated with the terminal dierentiation program (Figure 1 ). M1 leukemic myeloblasts, like their normal counterparts (Squier et al., 1995) , undergo apoptosis at the end of the terminal dierentiation program (Figure 1 ). Whether IRF-1 plays a role in apoptosis associated with terminal dierentiation remains to be determined. Yet, consistent with a role for IRF-1 in hematopoiesis, targeted disruption of IRF-1 revealed a critical role for IRF-1 in T cell development resulting in a profound reduction in TCRab + CD4-CD8 + T cells. Moreover, mice de®cient in IRF-2, an antagonistic repressor of IRF-1, exhibit bone marrow suppression of hematopoiesis and B lymphopoiesis, which likely is the re¯ection of disregulated expression of IRF-1 in hematopoietic cells (Matsuyama et al., 1993) .
Evidence has been obtained also that IRF-1 functions as a tumor suppressor gene whose loss of function contributes to leukemogenesis. This was ®rst suggested by the work of Willman et al. (1993) , who have demonstrated that the IRF-1 gene maps to human chromosome 5q31.1, a region which is frequently deleted in acute myeloid leukemia (AML) and preleukemic myelodysplasia (MDS). Subsequently it was observe that loss of IRF-1 function in AML/MDS patients also is due to exon-skipping in the error-prone IRF-1 mRNA (Harada et al., 1994; Mayeda et al., 1993) .
IRF-1, in conjunction with related IRF proteins, plays a central role in host immune and in¯ammatory responses (Taniguchi et al., 2001 and references therein.). IRF-1 is a key transcriptional activator of the IFNa/b genes in virus-infected cells, which is a central event in innate immunity (Janeway et al., 1999; Taniguchi et al., 2001 and references therein). In addition to anti viral responses, IRF-1 has been identi®ed as a key regulator of innate and adaptive host immune and in¯ammatory responses to bacterial infections, which are mediated by IFNg and other in¯ammatory cytokines (Taniguchi et al., 2001) . Major sources for IFNg are natural killer (NK) cells and Thelper type 1 (TH-1) CD4 + T cells (Nakanishi, 2001; Taniguchi et al., 2001 and references therein). In TH-1 cells, two distinct receptor-mediated pathways induce IFNg production (Nakanishi, 2001) . T cell receptor (TCR)-dependent IFNg production in response to IL-12 is antigen-speci®c and is considered to be part of the acquired immune response. On the other hand, dierentiated TH-1 cells, that express both IL-12 and IL-18 receptors produce IFNg directly in response to these cytokines. This second pathway, that enables TH-1 cells to participate in non-antigen-speci®c responses, is considered as part of the innate pathway of T cell activation. It was shown that activation of the gene encoding for the p40 subunit of IL-12 is completely dependent on IRF-1 (Loho et al., 1997; Taki et al., 1997) . IRF-1 also regulates IL-18 production and activity by modulating expression of caspase-1 and the IL-18 binding protein. In addition, IRF-participates in the induction of IFNg by IL-18 (Fantuzzi et al., 2001) . These ®ndings, thus, provide an explanation for the role IRF-1 plays in innate and adaptive immune responses of hematopoietic cells of the T cell lineage to bacterial infections.
IRF-1 has been also implicated in DNA damageinduced apoptosis of mitogen-activated mature T lymphocytes, which is p53 independent (Tamura et al., 1995) . Macrophage mediated tumor cell apoptotic death was found to involve IRF-1 as well. Tendler et
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Figure 1 Myeloid dierentiation (MyD) genes in hematopoietic dierentiation al. (2001) have shown that IRF-1 plays a major role in anti-tumor immunity which is conveyed by activated macrophages. Hypoxia stimulates IFN-primed macrophages to express the inducible nitric oxide synthase (NOS2) and to synthesize nitric oxide (NO). The synergy between IFN and hypoxia was shown to be mediated by direct interaction of the hypoxia inducible factor-1 (HIF-1) and IRF-1, both of which are required for the hypoxic transcription of NOS2. The interaction between HIF-1 and IRF-1 explains, at least partially, the mechanism by which macrophages in®ltrating into tumors are activated to express NOS2 and to produce NO which is a mediator of tumor apoptosis.
In conclusion, IRF-1 has multiple biological functions which appear to play a role in regulating blood cell homeostasis as well as immune and in¯ammatory responses of hematopoietic cells.
Jun/Fos transcription factors (MyD21, MyD42, MyD63) in hematopoietic differentiation and as modulators of stress induced apoptosis MyD21, MyD42, and MyD63 were identi®ed as MyD genes that encode for leucine zipper proteins that are rapidly and stably induced during dierentiation of M1 myeloblastic leukemia cells, and myeloblast enriched bone-marrow cells. Shortly after their isolation cloning of c-jun, JunB and JunD has been reported (Angel et al., 1988; Bos et al., 1988; Ryder et al., 1988 Ryder et al., ,1989 , and it became evident that MyD21, MyD42, and MyD63, encode for junB, c-Jun and JunD, respectively (Liebermann and Homan-Liebermann, 1989; Lord et al., 1990a,b) . The fact that jun mRNAs are stably induced during hematopoietic dierentiation suggests that Juns play key roles in the initiation, progression, and maintenance of the myeloid dierentiation program. C-jun, junB, and junD are components of the AP-1 family of homo-and hetero-dimeric leucine ziper transcription factors, which also includes Fos and Fos related proteins (Liebermann and Homan-Liebermann, 1989 and references therein). It has been established that Jun proteins homo-and heterodimerize with each other, whereas Fos proteins need Juns to form stable AP-1 complexes and references therein). Intriguingly, it was observed that though c-fos is stably induced during normal hematopoietic dierentiation, it is not induced upon terminal myeloid dierentiation of M1 myeloblastic leukemia cells (Lord et al., 1993) . Ectopic expression of Fos in M1 cells resulted in increased propensity of the cells to dierentiate in culture, and tempered their leukemogenicity in nude mice (Lord et al., 1993) . Blocking Fos expression, using c-fos antisense oligomers, impaired terminal dierentiation of normal, and M1 leukemic myeloblasts, implicating Jun/Fos as positive modulators of hematopoietic dierentiation. The fact that M1 cells expressing physiological levels of Fos, comparable to what is observed in dierentiating bone marrow, could not be established (Lord et al., 1993) has raised the possibility that high levels of c-fos expression in hematopoietic progenitor cells may be antagonistic to cell growth and/or cell survival. Indeed, expression of a b-estradiol inducible FosER chimera in M1 myeloblasts cultured in the absence of dierentiation inducer resulted in apoptotic cells death (Liebermann et al., 1998 and unpublished) , suggesting that under certain conditions of physiological and environmental stress Fos plays a role in monitoring hematopoietic progenitor cell survival (see below). The molecular nature of Jun/Fos transcription complexes that promote myeloid dierentiation and/or programmed cell death remains to be established. In recent years ample evidence has accumulated that Jun/Fos transcription complexes, indeed play a role in the development of hematopoietic precursor cells along most, if not all, of the hematopoietic cell lineages, including the monocyte/ macrophage, granulocyte, megakaryocyte, mastocyte, erythroid, and osteoclast lineages (reviewed in Jochum and . Notably, evidence has been obtained that Jun/Fos transcription complexes play a crucial role in the dierentiation program of osteoclasts, originating from hematopoietic progenitors that are common to the macrophage lineage (Grigoriadis et al., 1995; , and hence in bone remodeling (Johnson et al., 1992; Wang et al., 1992) . Most recently it was observed that transgenic mice which lack JunB expression in the myeloid lineage develop a transplantable myeloproliferative disease eventually progressing to blast crisis, resembling human chronic myeloid leukemia . This indicates that JunB is a key transcriptional regulator of myelopoiesis and a potential tumor suppressor gene. It is possible, therefore, that JunB/Fos heterodimeric complexes promote dierentiation. However, since c-fos de®cient mice do not display the phenotype observed in junB null mice, it is clear that other AP-1 homo-and/or hetero dimeric transcription complexes can compensate for the lack of Fos function.
In conclusion, Jun/Fos transcription complexes, appear to function in hematopoietic dierentiation and homeostasis, as well as in modulating programmed cell death in response to physiological and environmental stressors (Figure 1 ).
MyD19/HLM38: Egr-1-modulates hematopoietic lineage specific differentiation, and host stress responses MyD19 and HLM38 were identi®ed as myeloid dierentiation primary response cDNAs, encoding for similar zinc ®nger proteins, that are rapidly induced upon activation of terminal macrophage dierentiation in M1 myeloblastic leukemia cells and HL60 promyelocyic leukemia cells, respectively. Shortly after, it became evident that MyD19 and HLM38 encode for the mouse and human homologous of then the newly discovered zinc ®nger transcription factor EGR-1 (Christy et al., 1988; Milbrandt, 1987; Sukhatme et al., 1988) . That Egr-1 was speci®cally induced upon induction of macrophage, but not granulocyte, dier-entiation has suggested that EGR-1 may play a lineage speci®c role in hematopoietic development along the macrophage lineage. Indeed, using various myeloid dierentiation inducible cell lines, we have shown that EGR-1 is a positive modulator of macrophage dierentiation ( Figure 1 ) whose function varies, depending on the state of lineage commitment for dierentiation and the hematopoietic cell type. In HL60 cells, EGR-1 was found to block granulocytic dierentiation and restricted dierentiation to the monocytic lineage (Nguyen et al., 1993) . EGR-1 also blocked G-CSF-induced dierentiation of IL-3 dependent 32Dcl3 hematopoietic precursor cells, endowing the cells with the ability to be induced by GM-CSF for terminal dierentiation along the macrophage lineage (Krishnaraju et al., 1995) . Interestingly, EGR-1 also was found to mediate, in part, the ability of the homeobox gene Hox-B8 (Hox2.4) to endow 32Dcl3 cell with the potential to be induced by GM-CSF for terminal macrophage dierentiation (Krishnaraju et al., 1997) . Furthermore, ectopic expression of EGR-1 in M1 myeloblastic leukemia cells activated the macrophage dierentiation program, in the absence of the dierentiation inducer IL-6 (Krishnaraju et al., 1998) . Using high eciency retroviral transduction, recently it was shown that ectopic expression of EGR-1 in normal hematopoietic progenitors stimulated their development along the macrophage lineage at the expanse of development along the granulocyte and erythroid lineages, regardless of the cytokine(s) used (Krishnaraju et al., 2001) . Furthermore, EGR-1 was found to accelerate macrophage development by suppressing the proliferative phase. Consequently Egr-1 infected hematopoietic progenitors failed to repopulate the bone-marrow of lethally irradiated mice, further highlighting the role of EGR-1 in monocytic dierentiation and growth suppression. It has been reported that macrophage dierentiation is not aected in mice lacking the Egr-1 gene (Lee and Wang, 1996) . Increasing evidence indicates, however, that the other Egr family members, EGR-2, EGR-3 and EGR-4, share a high degree of structural and functional homology with EGR-1 (Liu et al., 1998; Tourtellotte et al., 2000) . Recently, we have observed that depending on the cytokine(s) that was used and the hematopoietic cell type, either one, two or all four members of the Egr family are induced during myeloid dierentiation (unpublished). Taken together, these observations strongly suggest that other member(s) of the Egr family are capable of compensating for the function of EGR-1 in macrophage development.
MyD88-a signal transducer in IL-1 and Toll receptor signaling: role in innate immunity, inflammation and apoptosis MyD88 was originally characterized as a novel MyD gene in M1 myeloblastic leukemia cells induced for terminal macrophage dierentiation by IL-6 (Lord et al., 1990d) . High levels of MyD88 are observed in myeloid enriched bone-marrow cells, suggesting a role for this gene in myeloid cell function/development. Interestingly, MyD88 immediate early induction, unlike other MyD genes, was found to be largely regulated at the level of mRNA stability (Lord et al., 1991) . The role of MyD88 in terminal myeloid dierentiation is still not fully understood. Given the role MyD88 plays in IL-1 and Toll-receptor signaling (see below), it is likely that induced expression of MyD88 in myeloid cells undergoing macrophage dierentiation serves to prime the cells to respond to IL-1 and pathogen associated motifs, respectively. Recent evidence has been obtained that in response to certain stimuli MyD88 also plays a role in dendritic cell maturation (Kaisho and Akira, 2001) .
The MyD88 encoded protein (35 kd) has a modular structure, consisting of an N-terminal death domain separated by a short linker from a C-terminal Toll domain (Feinstein et al., 1995; Hardiman et al., 1996; Hofmann and Tschopp, 1995; Hultmark et al., 1994; Mitcham et al., 1996; Yamagata et al., 1994) (Figure  2 ). The N-terminal death domain is related to a motif that originally was de®ned as the region of similarity between the cytoplasmic tails of the FAS/Apol/CD95 and TNF receptors that is required for cytotoxic signaling by the so called death receptors (Itoh and Nagata, 1993; Tartaglia et al., 1993) . The MyD88 Cterminal Toll domain, on the other hand, bears homology with the cytoplasmic signaling regions of the Drosophila melanogaster Toll receptor and the IL-1 receptor complex (Hashimoto et al., 1988; Medzhitov et al., 1998; Mitcham et al., 1996; Parnet et al., 1996) . IL-1 is known as an important mediator of in¯amma-tion, which participates in the defense response to environmental challenges by generating fever, activating lymphocytes, and mobilizing leukocytes to sites of injury and infection (Dinarello, 1996) . IL-1 exerts its eects by inducing the transcription of genes which encode for chemokines, cytokines, acute-phase liver proteins, cell adhesion molecules, and enzymes involved in the production of pro in¯ammatory substances (Barnes and Dinarello, 1996) . An important mediator of the IL-1 signaling cascade is NF-kB (Barnes and Baeuerle and Baltimore, 1996; Baldwin, 1996; Dinarello, 1996) , which is rendered inactive in the cytoplasm of unstimulated cells by inhibitory proteins termed IKB (Figure 2 ). Upon exposure of cells to cytokines or stress stimuli, IKB proteins are phosphorylated on speci®c serine residues, and consequently are degraded, leading to nuclear translocation and activation of NFkB Karin 1998) . Stimulation of cells with IL-1 results in association of the IL-1 type I receptor (IL-1 Rl) with the receptor accessory protein (IL-1RAcP) (Greenfeder et al., 1995; Huang et al., 1997; Korherr et al., 1997; Wesche et al., 1997b) . Consequently, the IL-1 receptor-associated serine/ threonine kinase (IRAK) is recruited to the receptor complex, where it is phosphorylated (Cao et al., 1996a) . IRAK then dissociates from the receptor complex and interacts with TRAF6, which is required for IL-1 mediated activation of NF-kB (Cao et al., 1996b) (Figure 2) . Two other TRAF (TNF-receptor associated factor) proteins, TRAF2 and TRAF5, have been implicated in NF-kB activation by the superfamily of TNF receptors (Aizawa et al., 1997; Duckett et al., 1997; Hsu et al., 1996a; Ishida et al., 1996; Nakano et al., 1996; Rothe et al., 1995) , indicating that IL-1 and TNF signaling converge at the level of TRAF molecules. The kinase cascade which is distal to TRAF, and is responsible for NF-kB activation, consists of a kinase complex that is composed of the TRAF interacting and NF-kB inducing kinase-NIK, and two IKB kinases (IKKa and IKKb) that phosphorylate IKB on speci®c serine residues (Di Donato et al., 1997; Malinin et al., 1997; Mercurio et al., 1997; Regnier et al., 1997; Song et al., 1997; Woronicz et al., 1997; Zandi et al., 1997) (Figure 2) .
The IL-1Rl and IL-1RAcP both belong to a conserved family of receptor like molecules, including IL-1 Rrp, IL-1Rrp2, T1/ST2, rsc786/TIL, human Toll in mammals (Mitcham et al., 1996; Lovenberg et al., 1996; Parnet et al., 1996; Medzhitov et al., 1997; Yanagisawa et al., 1993) , RPP5 in plants (Parker et al., 1997) , and 18 Wheeler and Toll in Drosophila (Eldon et al., 1994; Hashimoto et al., 1988) . In Drosophila the Toll pathway governs an ancient innate immune response (Lemaitre et al., 1996) . In addition, this pathway controls dorsal-ventral polarization during early embryonic development (Belvin and Anderson, 1996; Norris and Manley, 1996; Wasserman, 1993) . Analogous to IL-1 signaling, activation of the cell surface receptor Toll by the extra cellular ligand Spaetzle was shown to lead to the phosphorylation and degradation of the IKB-like molecule Cactus, resulting in release and translocation of the NF-kB-like transcription factor Dorsal to the nucleus (Letsou et al., 1993; Norris and Manley, 1996; Shelton and Wasserman, 1993) (Figure 2 ). Dorsal activation signaled by Toll requires two intermediate signal transducers, Tube and Pelle (Letsou et al., 1993; Norris and Manley, 1996; Shelton and Wasserman, 1993) . Pelle is a serine/threonine kinase that is related by its sequence to IRAK, whereas Tube is an adapter molecule that links Pelle to the Toll receptor (Galindo et al., 1995; Grosshans et al., 1994) (Figure 2 ). Tube and Pelle were observed to interact via their N-terminal death domains, a motif which is also present in many Figure 2 MyD88 is a signal transducer in signaling by the IL-1, IL-18, and Toll receptors. MyD88 has a modular structure, consisting of an N-terminal death domain (DD) and C-terminal Toll domain (TD). MyD88 is an adapter that recruits the serine/ threonine kinase IRAK to the IL-1, IL-18 and human Toll receptors. MyD88 is upstream of a regulatory cascade, which activates NF-kB and AP-1. MyD88 is, the mammalian homologue of Drosophila Tube, and a functional equivalent of TRADD, a signal transducer in TNF signaling. TRADD, interacts with RIP/TRAF2 to activate NF-kB, and with FADD to activate caspase 8 and apoptosis. MyD88 is capable of inducing apoptosis. Whether it functions like TRADD remains to be seen other signal transducing molecules, including IRAK (Cao et al., 1996a; Feinstein et al., 1995; Galindo et al., 1995) .
In recent years it has become evident that MyD88 is the mammalian homolog of drosophila Tube, that recruits IRAK to the IL-1 receptor complex Muzio et al., 1997; Wesche et al., 1997a) thereby coupling a serine/threonine protein kinase to the IL-1 receptor complex which ultimately results in activation of NF-kB and Jun/Fos transcription factor complexes (Figure 2) .
MyD88 also has been identi®ed as an adapter for activation of NF-kB and AP-1, via the IRAK/TRAF6 cascade, in signaling by human Toll-like-receptors (TLRs) that play important roles in the innate immune response which is the ®rst line of defense against infectious diseases (Aderem et al., 2001; Medzhitov et al., 1998) (Figure 2 ). For example, the in¯ammatory response to Gram-negative bacterial endotoxin (lipopolysaccharide (LPS)), that plays a key role in the septic shock syndrome due to its profound eects on the innate immune system, is conveyed by TLR4 and is dependent on MyD88, as evident by the unresponsiveness of MyD88-de®cient mice to endotoxin (Aderem et al., 2001 and references therein; Kawai et al., 1999) (Figure 2 ). Consistent with this notion, recently it has been reported that the Lps(d) mutation abolishes Toll receptor signaling by disrupting recruitment of MyD88 (Xu et al., 2000) . Also it has become evident that endotoxin tolerance, which is a common phenomenon in blood from sepsis patients, involves the inability of IRAK to associate with MyD88 in tolerant cells.
Gene targeting of MyD88 in mice has shown that mice lacking MyD88 have defects in T cell proliferation, as well as in the induction of acute phase liver proteins and cytokines in response to IL-1 (Adachi et al., 1998) . Interestingly, MyD88 null mice also exhibit defects in IL-18 signaling via the IL-1 related receptor-IL-Rrp. (Adachi et al., 1998) . Both the increase in IFNg production and natural killer cell activity in response to IL-18 are compromised in MyD887/7 mice. IL-18-induced activation of NF-kB and JNK also was impaired in MyD887/7Th1-thymocyts. These observations indicate that MyD88 is a critical component in the IL-1 and IL-18 signaling cascades. The fact that MyD88 gene disruption was not lethal, and did not eect early embryo development in mice, is consistent with the notion that other MyD88 like molecules which play critical roles in Toll signaling in mammal development might exist.
Identi®cation of MyD88 as an adapter molecule that recruits IRAK to the IL-1 receptor complex extends the conservation found in the signaling pathways for IL-1 and TNF, two major cytokines that activate NFkB (Figure 2 ). The TNFR1 complex was shown to recruit the death domain-containing molecule TRADD (Hsu et al., 1995) , which mediates NF-kB activation and apoptosis. To activate NF-kB, TRADD interacts with the serine/ threonine kinase RIP and TRAF2, that are linked to the NIK/IKK cascade, and trigger the phosphorylation and degradation of IKB (Hsu et al., 1996a,b) . On the other hand, to induce cell death, TRADD interacts with FADD, which in turn triggers the apoptotic caspase cascade (Boldin et al., 1996; Grimm et al., 1996; Hsu et al., 1996a; Muzio et al., 1996) . Thus, in IL-1 signaling MyD88 is the functional equivalent of TRADD. Indeed, recently a role for MyD88 in programmed cell death has been established. Ectopic expression of MyD88 in human cervical carcinoma HeLa cell was observed to induce apoptosis (Jaunin et al., 1998) . Dominant negative MyD88 proteins inhibit interleukin-1b/interferon-g-mediated induction of NF-kB-dependent nitrite production and apoptosis in pancreatic b cells (Dupraz et al., 2000) . Evidence has been obtained that MyD88 also mediates apoptosis and activation of NF-kB upon activation of Toll receptor signaling by LPS (Schmidt et al., 2001 ).
In conclusion, MyD88 ful®ls important functions in innate immunity, and in¯ammation and in its associated programmed cell death (Figure 1 ). Whether MyD88 also functions in regulating blood cell homeostasis remains to be explored.
MyD116-viral homologs and role in apoptosis
MyD116 is the second novel MyD gene that was isolated in our laboratory (Lord et al., 1990c) . Like other MyD genes it is rapidly induced by IL-6 in M1, and expressed in bone-marrow cells. Following its isolation, it became evident that MyD116 is the murine homolog of Gadd34, that was isolated by virtue of its being activated in hamster cells by growth arrest and DNA-damage stimuli, including alkylating agents and irradiation Zhan et al., 1994 ). An interesting feature of the MyD116/ GADD34 proteins are the almost perfect 38/39aa long repeats, each containing a PEST motif, implicated in rapid protein turnover. Each PEST motif contains three potential casein kinase II phosphorylation sites, the function of which is still unclear. Interestingly, MyD116 contains 4 repeats, whereas GADD34 harbors only 3 repeats . Cellular localization of the MyD116 protein has revealed that MyD116 is present both in the cytoplasm and in the nucleus of cells (unpublished). Using subtraction hybridization, a genetermed PEG3, associated with transformation progression of virus-and oncogene-transformed rat embryo cells, has been cloned as a new member in the MyD116/Gadd34 family (Zhang et al., 1999) .
Interestingly, the conserved carboxy terminal domain of MyD116, was found to share striking homology to the corresponding domain in the g(1)34.5 gene of herpes simplex virus (HSV) (Su et al., 1997) . The HSV g(1)34.5 gene is essential for establishment of acute infection by HSV. Deletion mutants, of g(1)34.5 trigger a premature shuto of all protein synthesis, thereby rendering the cell non viable and preventing acute infection (164). The g(1)34.5 domain necessary to preclude the total shuto of protein synthesis was mapped to the carboxyl-terminal domain of the g(1)34.5 protein, which is highly homologous to the corresponding domains in MyD116 and GADD34 (Chou and Roizman, 1994) . It was shown that the carboxyl terminus of murine MyD116 can substitute for the corresponding domain of g(1)34.5 of HSV to preclude premature shuto of protein synthesis in infected human cells (He et al., 1996) . The g(1)34.5 protein of HSV1 was found to complex with protein phosphatase-1a. This interaction results in dephosphorylation of the a subunit of the eukaryotic translation initiation factor 2, thereby precluding the shuto of protein synthesis by double-stranded RNAactivated protein kinase. The MyD116 homology domain has been implicated in this interaction (He et al., 1997) . Also the African swine fever virus virulenceassociated gene, termed NL-S, encodes for a protein with a carboxy terminal domain which is similar to the carboxy terminal domain of MyD116 and the HSV g(1)34.5 protein (Sussman et al., 1992; Vydelingum et al., 1993; Dixon et al., 1994; Zsak et al., 1996) . Whether other viruses harbor similar genes that upon viral infection promote cell survival remains to be seen. Curiously, ectopic expression of mammalian MyD116 was found to suppress tumor cells growth . On the other hand, blocking MyD116 expression by antisense oligos was observed to promote hematopoietic cell survival, suggesting that MyD116 plays a role in terminal dierentiation associated apoptosis (unpublished). Furthermore, cellular MyD116/GADD34 has been reported to be induced by diverse apoptotic stimuli, in a way which suggests that activation of MyD116/GADD34 is a downstream event in apoptotic signaling pathways and may directly contribute to the apoptotic process (Hollander et al., 2001; Amundson et al., 2000) . Thus, MyD116/ GADD34 and g(1)34.5 appear to play opposing roles, where MyD116/GADD34 seems to induce apoptosis while g(1)34.5 inhibits apoptosis in virally-infected cells. Recently MyD116/GADD34 has been implicated in dephosphorylation of eIF2alpha in a negative feedback loop that inhibits stress-induced gene expression, and that might promote recovery from translational inhibition in the unfolded protein response (Novoa et al., 2001) . Interestingly, leukemic HRX fusion proteins were found to inhibit MyD116/ GADD34-induced apoptosis via association with the MyD116/GADD34 protein, suggesting that MyD116/ GADD34 function plays a role in suppression of leukemia (Adler et al., 1999) .
Both the g(1)34.5 gene of HSV and MyD116/ GADD34 were reported to interact, via their conserved C-terminal domains, with proliferating cell nuclear antigen (PCNA) (Brown et al., 1997) , an important player in DNA replication and DNA repair. The signi®cance of this interaction remains to be determined. MyD116 was also found to interact with KIF3A, a kinesin superfamily protein, (Hasegawa et al., 2000a) , with a new member of the Hsp40 family of heat shock proteins that is induced by a DNAdamaging agents (Hasegawa et al., 2000b) , with Translin ± a protein that is known to bind to the DNA sequences detected in the DNA translocation (Hasegawa and Isobe, 1999a ) and with a zinc-®nger transcription factor that binds to the p21 promoter (Hasegawa et al., 1999b) . The biological signi®cance of these interactions remains to be established as well.
Thus, MyD116/GADD34, like some of the other MyD proteins, appears to play a role in regulating programmed cell death associated with terminal dierentiation of hematopoietic cells MyD118(GADD45b), Gadd45a, and CR6(GADD45g) ± a family of growth suppressive and apoptotic proteins which interact with cell cycle proteins MyD118 was the third novel gene isolated in our laboratory (Abdollahi et al., 1991b) . Shortly after its isolation it became evident that MyD118 is related to the Gadd45 gene. The proteins encoded by these genes are 57% identical, indicating that MyD118 and Gadd45 represent two separate but closely related genes . Recently, the full length sequences of murine and human CR6 cDNAs, respectively, have been determined (Takekawa and Saito, 1998; Zhang et al., 1999) .
The MyD118/CR6/Gadd45 gene family (also termed Gadd45b, Gadd45g, Gadd45a (Takekawa and Saito, 1998)) encodes for small (18 kd), evolutionary conserved proteins that are highly homologous to each other (55 ± 57% overall identity at the amino acid level), are highly acidic (pI=4.0 ± 4.2), and are primarily localized within the cell nucleus (Takekawa and Saito, 1998; Zhang et al., 1999) .
The GADD45 family of proteins are rapidly induced by genotoxic agents Papathanasiou et al., 1991; Zhan et al., 1994) as well as by terminal dierentiation and apoptotic cytokines (Abdollahi et al., 1991b; Zhan et al., 1994; Zhang et al., 1999; Vairapandi et al., 1996) . In recent years evidence has emerged that these proteins play pivotal roles in negative growth control, either dependent or independent of p53, including the response of mammalian cells to genotoxic stress Zhang et al., 1999) .
Data accumulated, so far, suggests that MyD118/ CR6/GADD45 serve similar, but not identical, functions along dierent apoptotic and growth inhibitory pathways. For example, we have observed that MyD118, but not Gadd45, is activated upon TGF-b1 induced apoptosis (Selvakumaran et al., 1994b) . On the other hand, Gadd45, but not MyD118 or CR6, was identi®ed as a target for p53 function (Selvakumaran et al., 1994a; Guillouf et al., 1995; Kastan et al., 1992) . All three genes are induced with dierent expression kinetics during terminal hematopoietic dierentiation, which is associated with growth arrest and apoptosis (Zhang et al., 1999) . Distinct expression patterns for these genes were observed also in a variety of murine tissues (Zhang et al., 1999) . Importantly, individual members of the GADD45 gene family are dierentially induced by a variety of genetic and environmental stress agents; this suggests that each gene is induced by a distinct subset of environmental stresses (Shaulian Oncogene MyD/Gadd as therapeutic targets DA Liebermann and B Hoffman and Karin, 1999; Takekawa and Saito 1998; Wang et al., 1999a; Zhang et al., 1999 Zhang et al., , 2001 Zhang, 2000) . Short term transfection assays have revealed that MyD118/CR6/GADD45 synergize to suppress colony formation of several human tumor cell lines Zhang et al., 1999) . To what extent the function of each of the MyD118/CR6/GADD45 proteins is unique or overlaps with the functions of the other proteins, remains to be determined.
GADD45 proteins have been implicated in cell cycle arrest (Beadling et al., 1993; Zhang et al., 1999; Hollander et al., 1999) , DNA repair (Smith et al., , 2000 Vairapandi et al., 1996) , apoptosis Harkin et al., 1999; Takekawa and Saito, 1998; Vairapandi et al., 2000; Zhang et al., 2001; Zhang, 2000) , cell survival (Smith et al., 1996 (Smith et al., , 2000 , and innate immunity (Lu et al., 2001; Yang et al., 2001) (Figure 1) .
Microinjecting a GADD45a expression vector into primary human ®broblasts arrested the cells at the G2/ M boundary of the cell cycle (Wang et al., 1999b) . The ability of GADD45a to mediate G2/M arrest appears to depend on wild-type p53, since no arrest was observed in p53-null cells. Inhibiting endogenous Gadd45a expression by antisense Gadd45 expression, impaired G2/M checkpoint following exposure to UV radiation or MMS, but not following exposure to IR. These observations indicate the existence of multiple G2/M checkpoints, which are activated in response to dierent stress agents. Keeping in mind that Gadd45 is a transcriptional target for p53, these observations implicate Gadd45 in p53 mediated G2/M cell cycle arrest in response to certain genotoxic stress agents (Wang et al., 1999b) . Recent data also indicate that MyD118/GADD45b and CR6/GADD45g play a role in G2/M cell cycle arrest (Vairapandi et al., 2001) . Gadd45a de®cient mice were observed to exhibit genomic instability and increased radiation carcinogenicity (Hollander et al., 1999) . The genomic instability observed in Gadd45a null mice may re¯ect perturbations in one or more of the controls that regulate G2/M cell cycle progression.
Many observations are also consistent with a role for MyD118/CR6/GADD45 in programmed cell death. Blocking MyD118 expression via antisense transgenes in M1 myeloblastic leukemia cells impaired TGFb induced cell death, implicating MyD118 as a positive modulator of TGFb induced apoptosis (Selvakumaran et al., 1994b) . IPTG-inducible ectopic expression of MyD118 or CR6 accelerated TGFb induced apoptosis in M1 cells (Zhang, 2000) , and enhanced apoptosis induced by genotoxic stress agents in both M1 and H1299 lung carcinoma cells (Zhang et al., 2001) . Moreover, transient transfection of MyD118, Gadd45, or CR6 into H1299 cells resulted in apoptotic cell death Takekawa and Saito, 1998; Vairapandi et al., 2000) . Recently, GADD45a has been implicated also in p53-independent BRCA-1-mediated apoptosis of breast cancer cells (Harkin et al., 1999; Li et al., 2000) . Furthermore, overexpression of GADD45g by microinjection of an expression vector into normal neurons cultured in the presence of NGF resulted in cell death (Kojima et al., 1999) . Curiously, evidence has been obtained that, under certain conditions, GADD45 proteins promote cell survival. Clonogenic survival assays with Gadd45a7/7 MEFs (Smith et al., 2000) and RKO cells expressing antisense Gadd45a RNA (Smith et al., 1996) have shown that de®ciency of GADD45 increases the sensitivity of cells to killing by UV irradiation or cisplatin. It appears, therefore, that the stress stimulus encountered, the cell type, its physiological state, its genetic makeup, and interaction with other proteins (see below) modulate GADD45 proteins function to determine whether the outcome will be cell cycle arrest, DNA repair and cell survival or apoptotic cell death.
Evidence has accumulated that MyD118/CR6/ Gadd45 display a complex array of physical interactions with each other (Kovalsky et al., 2001; D Liebermann, unpublished) , as well as with other cellular proteins implicated in cell cycle regulation and the response of cells to extrinsic stress. All three GADD45 proteins interact with PCNA Vairapandi et al., 1996) , a nuclear protein that plays a central role in DNA repair and replication, and in at least one apoptotic pathway (Jonsson and Hubsche, 1997; Kelman and Hurwitz, 1998; Sancar, 1994 , and references therein). Recently, evidence has been obtained that GADD45a interaction with PCNA plays a role in nucleotide excision repair of DNA (Smith et al., 2000) . Recent evidence suggests that interaction of GADD45 proteins with PCNA in essence impedes their apoptotic function Vairapandi et al., 2000) . Whether interaction of GADD45b and GADD45g with PCNA plays a role in DNA repair remains to be seen. Recently interaction of GADD45a with p33(ING1) also has been observed and suggested to play a role in NER (Cheung et al., 2001) . Whether Gadd45b and/or GADD45g interact with ING1 is not known. Interaction of GADD45a with DNA and core histones has been reported recently , and it has been suggested that also this interaction is linked to Gadd45a function in DNA repair.
Gadd45 proteins also interact with cdc2 (Cdk1), resulting in inhibition of the kinase activity of the cdc2/ CyclinB1 complex (Jin et al., 2000; Yang et al., 2000; Zhan et al., 1999) . Since cdc2/cyclinB1 is known as a key regulator of the transition from G2 to the M phase of the cell cycle (Elledge, 1996; Vairapandi et al., submitted) , interaction of Gadd45 proteins with cdc2 is implicated in GADD45-mediated activation of the G2/ M checkpoint in response to genotoxic stress (Wang et al., 1999b) . All three GADD45 proteins were also found to interact Vairapandi et al., 1996) with the universal cyclin dependent kinase inhibitor p21 (Harper et al., 1993; Zhang et al., 1993; Xiong et al., 1993) , a p53 target gene (El-Deiry et al., 1993) implicated in G1/S (Deng et al., 1995) and G2/M (Chan et al., 2000) cell cycle arrest. The role of GADD45 interactions with p21 is still unclear. GADD45 proteins also interact with and activate the stress-responsive MTK1/MEKK4 kinase, which is an upstream activator of the p38/JNK kinase pathways implicated in environmental stress induced apoptosis (Takekawa and Saito, 1998) . However, the signi®cance of GADD45 interactions with MEKK4 in activation of the stress responsive JNK/p38 apoptotic pathways is still undetermined (Shaulian and Karin, 1999; Wang et al., 1999a) . Recently it has been suggested that GADD45b and GADD45g activation of JNK/p38 plays an essential role in cytokine induced (innate) IFNg production by TH-1 thymocytes (Lu et al., 2001; Yang et al., 2001) . Finally GADD45 proteins are also capable of homo-and hetero-interactions among themselves (Kovalsky et al., 2001; D Liebermann, unpublished ) . The multitude of GADD45 interacting partners raises the interesting possibility that the nature/magnitude of stress encountered, and the extent of cellular/DNA damage may dictate association of GADD45 with particular partners, to determine the appropriate outcome, i.e. cell cycle arrest, DNA repair and cell survival or programmed cell death. Clearly, much data is still needed to better understand how the intricate network of GADD45 interactions with other cell cycle and stress response proteins mediates their diverse functions.
Recently, in collaboration with the group of Dr Albert Fornace at the NCI.NIH, mice de®cient for either one or more of the GADD45 family of proteins have been generated. Using these Gadd45 de®cient strains of mice, evidence is emerging that GADD45 proteins play a role in regulating homeostasis of hematopoietic tissues by modulating both the cell cycle and apoptosis in response to dierentiation and growth inhibitory cytokines, such as TGFb, and in response to genotoxic stress (unpublished observations). Thus alterations in expression of GADD45 proteins are expected to modify cell cycle controls and survival, and to manifest itself by changing the distribution of dierent lineages and stages of maturation of hematopoietic cells. Understanding how these proteins function to regulate blood cell homeostasis, and responses to stress should contribute to a greater understanding of the genetic events involved in the pathogenesis of dierent leukemias and the response of normal and malignant hematopoietic cells to chemo-and radiationtherapy, ultimately aiding in diagnosis, prognosis and therapy.
